Larson, Martin G.

Framingham risk score and prediction of lifetime risk for coronary heart disease

Lloyd-Jones, D. M., Wilson, P. W. F., Larson, M. G., Beiser, A., Leip, E. P., D'Agostino, R. B., & Levy, D. (2004) · The American Journal of Cardiology

Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

Cited by 566

Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis

Wilson, P. W. F., Schaefer, E. J., Larson, M. G., & Ordovas, J. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 539

Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study

Rutter, M. K., Parise, H., Benjamin, E. J., Levy, D., Larson, M. G., Meigs, J. B., Nesto, R. W., Wilson, P. W. F., & Vasan, R. S. (2003) · Circulation

Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 511

Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study

Demissie, S., Levy, D., Benjamin, E. J., Cupples, L. A., Gardner, J. P., Herbert, A., Kimura, M., Larson, M. G., Meigs, J. B., Keaney, J. F., et al. (2006) · Aging Cell

Telomeres, Telomerase, and SenescenceCardiovascular Health and Disease Prevention

Cited by 508

The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., et al. (2018) · JACC: Heart Failure

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 499

Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Vasan, R. S., Benjamin, E. J., Larson, M. G., Leip, E. P., Wang, T. J., Wilson, P. W. F., & Levy, D. (2002) · JAMA

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 493

Predicting Survival in Heart Failure Case and Control Subjects by Use of Fully Automated Methods for Deriving Nonlinear and Conventional Indices of Heart Rate Dynamics

Ho, K. K. L., Moody, G. B., Peng, C.-K., Mietus, J. E., Larson, M. G., Levy, D., & Goldberger, A. L. (1997) · Circulation

Heart Rate Variability and Autonomic ControlECG Monitoring and Analysis

Cited by 489

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation

GDF15 and Related BiomarkersHeart Failure Treatment and Management

Cited by 482

Accuracy of Death Certificates for Coding Coronary Heart Disease as the Cause of Death

Lloyd-Jones, D. M., Martin, D. O., Larson, M. G., & Levy, D. (1998) · Annals of Internal Medicine

Medical Coding and Health InformationHealthcare Systems and Public Health

Cited by 480

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)

Singh, J. P., Larson, M. G., O’Donnell, C. J., Wilson, P. F., Tsuji, H., Lloyd-Jones, D. M., & Levy, D. (2000) · The American Journal of Cardiology

Heart Rate Variability and Autonomic ControlDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 439

Genome‐wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease

Yao, C., Chen, G., Song, C., Keefe, J., Mendelson, M., Huan, T., Sun, B. B., Laser, A., Maranville, J. C., Wu, H., et al. (2018) · Nature Communications

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 431

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction

Vasan, R. S., Larson, M. G., Benjamin, E. J., Evans, J. C., & Levy, D. (1997) · New England Journal of Medicine

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 402

Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry

Benjamin, E. J., Rice, K. M., Arking, D. E., Pfeufer, A., van Noord, C., Smith, A. V., Schnabel, R. B., Bis, J. C., Boerwinkle, E., Sinner, M. F., et al. (2009) · Nature Genetics

Atrial Fibrillation Management and OutcomesGenetic Associations and Epidemiology

Cited by 390

Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation

Lubitz, S. A., Yin, X., Fontes, J. D., Magnani, J. W., Rienstra, M., Pai, M., Villalon, M. L., Vasan, R. S., Pencina, M. J., Levy, D., et al. (2010) · JAMA

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 313

A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction

Rhee, E. P., Clish, C. B., Ghorbani, A., Larson, M. G., Elmariah, S., McCabe, E., Yang, Q., Cheng, S., Pierce, K., Deik, A., et al. (2013) · Journal of the American Society of Nephrology

Metabolomics and Mass Spectrometry StudiesChronic Kidney Disease and Diabetes

Cited by 307

Prognostic Implications of Asymptomatic Ventricular Arrhythmias: The Framingham Heart Study

Bikkina, M., Larson, M. G., & Levy, D. (1992) · Annals of Internal Medicine

Cardiac electrophysiology and arrhythmiasCardiac Health and Mental Health

Cited by 266

Distribution and Categorization of Echocardiographic Measurements in Relation to Reference Limits: The Framingham Heart Study: Formulation of a Height- and Sex-Specific Classification and Its Prospective Validation

Vasan, R. S., Larson, M. G., Levy, D., Evans, J. C., & Benjamin, E. J. (1997) · Circulation

Cardiovascular Function and Risk FactorsCardiovascular Effects of Exercise

Cited by 248

SOCIAL NETWORKS AND INFLAMMATORY MARKERS IN THE FRAMINGHAM HEART STUDY

LOUCKS, E. B., SULLIVAN, L. M., D’AGOSTINO Sr, R. B., LARSON, M. G., BERKMAN, L. F., & BENJAMIN, E. J. (2006) · Journal of Biosocial Science

Health disparities and outcomesCardiac Health and Mental Health

Cited by 247

Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes

Meigs, J. B., Larson, M. G., Fox, C. S., Keaney, J. F., Vasan, R. S., & Benjamin, E. J. (2007) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsAntioxidant Activity and Oxidative Stress

Cited by 220

Glycemic Status and Development of Kidney Disease

Fox, C. S., Larson, M. G., Leip, E. P., Meigs, J. B., Wilson, P. W. F., & Levy, D. (2005) · Diabetes Care

Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 197

Association of parental heart failure with risk of heart failure in offspring

Lee, D. S., Pencina, M. J., Benjamin, E. J., Wang, T. J., Levy, D., O'Donnell, C. J., Nam, B.-H., Larson, M. G., D'Agostino, R. B., & Vasan, R. S. (2006) · New England Journal of Medicine

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 191

Influence of sex and hormone status on circulating natriuretic peptides

Lam, C. S. P., Cheng, S., Choong, K., Larson, M. G., Murabito, J. M., Newton-Cheh, C., Bhasin, S., McCabe, E. L., Miller, K. K., Redfield, M. M., et al. (2011) · Journal of the American College of Cardiology

Hormonal and reproductive studiesHeart Failure Treatment and Management

Cited by 181

Genome-wide identification of microRNA expression quantitative trait loci

Huan, T., Rong, J., Liu, C., Zhang, X., Tanriverdi, K., Joehanes, R., Chen, B. H., Murabito, J. M., Yao, C., Courchesne, P., et al. (2015) · Nature Communications

Genetic Associations and EpidemiologyMicroRNA in disease regulation

Cited by 179

Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study

Liu, C. K., Lyass, A., Larson, M. G., Massaro, J. M., Wang, N., D’Agostino, R. B., Benjamin, E. J., & Murabito, J. M. (2016) · AGE

Frailty in Older AdultsCardiovascular Health and Disease Prevention

Cited by 157